Developer docs
API playgroundTry for free, no card

Search company profiles

CelVivo

Full company profile

uuid0009zwa

Namestring
CelVivo
Legal namestring
CelVivo ApS
Websiteurl
celvivo.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

CelVivo ApS is a Danish biotechnology company founded in 2014 and headquartered in Odense, Denmark, with a wholly-owned US subsidiary (CelVivo, Inc.) in Chevy Chase, Maryland. It develops and sells clinostat-based 3D cell culture systems that grow cells in a stress-free, low-shear laminar-flow environment intended to mimic in vivo physiological conditions for organoid development, tissue engineering, and related research. Its core hardware products are the ClinoStar 2 (a clinostat integrated into a CO2 incubator) and the ClinoReactor (a patent-pending single-use bioreactor with a 10 mL growth chamber), supplemented by a Hypoxia Module accessory and the CelVivo Cloud remote-monitoring service. The technical narrative centers on the "RARE" framework — Relevance, Abundance, Reproducibility, Ease — claiming up to 100% utilization of cell cultures and superior organoid growth versus conventional methods.

CelVivo sells capital equipment, single-use consumables, and after-sales service to academic and research institutions, pharmaceutical and biotechnology companies, and medical research groups. The business model is hardware-led with a consumable and service tail: pricing is quote-based against an unpublished price list, payment terms are typically 30 days from invoice, and up to 50% advance payment may be required. Distribution combines direct sales — handled in-house for the Americas via the US subsidiary — with a network of named regional distributors covering APAC (e.g., Yamato Scientific in Japan, Sino BioTool in China), Central and Southern Europe (e.g., ALAB in Poland, Cytosens in Italy and Spain), the Middle East and Africa (Seperations in South Africa), and additional partners in Singapore, Korea, India, Taiwan, the Czech Republic, and Switzerland. A co-development partnership with TheWell Bioscience integrates Vitrogel hydrogel into the ClinoReactor workflow for cell lines with insufficient natural ECM production.

The company is privately held and bootstrapped, with 1-10 employees and no disclosed funding rounds, revenue, or institutional investors in the available source material. It protects its technology through registered trademarks for ClinoStar and ClinoReactor and a patent-pending filing on the ClinoReactor bioreactor. The operating footprint spans roughly 35+ countries, though no quantitative revenue or growth data is publicly disclosed, and named customer logos are predominantly individual academic and research institutions rather than large anchor enterprise accounts.

Short descriptiontext

CelVivo is a Danish biotech company that develops clinostat-based 3D cell culture hardware (ClinoStar 2 and ClinoReactor) plus consumables and a cloud monitoring service, selling primarily to academic researchers, pharmaceutical/biotech firms, and medical research groups via direct sales and a global distributor network spanning 35+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOdense, Denmark
HQ citystring
Odense
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D cell culture, organoid technology, laboratory bioreactors, clinostat equipment, cell culture instruments
Industry2 codes
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
3D Cell Culture Laboratory Instruments
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
13D Cell Culture Equipment Sales
TypeHardware Sales
Description

Sale of ClinoStar and ClinoReactor systems for 3D cell culture, including hardware and control units. The ClinoStar has a 1-year warranty from delivery date.

celvivo.com
2Consumables
TypeHardware Sales
Description

Sale of ClinoReactor consumables. The ClinoReactor has a shelf life of 1 year and is sterilized via e-beam. Operating time in incubator is 10 days. Consumables are not covered by warranty.

celvivo.com
3After-Sales Service and Repairs
TypeProfessional Services
Description

CelVivo provides after-sales service and repairs on all products. Cost for repair and transport is covered by the buyer if outside warranty.

celvivo.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom pricing based on product configuration and volume
ModelOtherBilling cadenceAnnual
Notes

All purchases are subject to prices defined in CelVivo's pricelist at the time of order. Prices are subject to change. No specific tier structures or pricing tiers are publicly disclosed.

celvivo.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1ClinoStar
Description

A clinostat for 3D cell culture incorporated in a CO2 incubator, allowing culture of cells in 3D in a single unit. The most user-friendly system for working with organoids.

celvivo.com
+4 more records
Core offering1 text field

CelVivo designs, manufactures, and sells hardware and consumables for 3D cell culture. Its flagship ClinoStar 2 system is a clinostat that fits inside a standard CO2 incubator to grow organoids and tissue in a low-shear, stress-free environment. The company complements the platform with the ClinoReactor single-use bioreactor, a Hypoxia Module accessory, and the Celvivo Cloud remote monitoring service.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 100% utilization of cell cultures
+2 more records
Product overview1 text field

CelVivo offers a unified 3D cell culture system centered on the ClinoStar 2 platform, a clinostat-based device that incorporates directly into standard CO2 incubators. The system is complemented by the ClinoReactor, a single-use all-in-one bioreactor with a 10 mL growth chamber, and the Hypoxia Module for low-oxygen research applications. The Celvivo Cloud service adds remote monitoring and control capabilities, allowing researchers to monitor experiments from any location. Together, these products enable stress-free 3D cell and organoid culture with full reproducibility and relevance to in vivo conditions.

Product and service4 records
1ClinoStar 2
Category3D Cell Culture Equipment
Description

The ClinoStar 2 is a clinostat for 3D cell culture that fits inside a standard CO2 incubator, enabling users to culture cells in 3D within a single unit. It provides a stress-free, low-shear environment for organoid development and tissue engineering, with remote monitoring via Celvivo Cloud, push-button auto decontamination, and stand-alone ergonomic design that eliminates the need for laminar flow bench work. It is sold to academic researchers, pharmaceutical R&D teams, and biotech laboratories.

2ClinoReactor
Category3D Cell Culture Consumables and Bioreactors
Description

The ClinoReactor is a single-use, all-in-one bioreactor with a 10 mL growth culture chamber, semi-permeable membrane for CO2 equilibrium, and an integrated humidification system. Its front wall doubles as a click-on/off lid, providing petri-dish-like access to the chamber, and it operates for 10 days inside an incubator with a one-year shelf life and e-beam sterilization. It is sold as a consumable used with the ClinoStar platform for 3D cell culture workflows.

3Hypoxia Module
Category3D Cell Culture Equipment Module
Description

The Hypoxia Module is an add-on for the ClinoStar system that allows researchers to control oxygen conditions, enabling experiments under low-oxygen (hypoxic) environments for studying tumor microenvironments and other oxygen-related biological questions.

4Celvivo Cloud
CategoryCloud Monitoring Software Service
Description

Celvivo Cloud is a cloud-based remote monitoring and control service that lets ClinoStar users monitor and manage their cell culture environment from any device, anywhere in the world. It is offered to ClinoStar owners as an add-on service.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CelVivo has partnered with TheWell Bioscience to integrate Vitrogel hydrogel matrix into the ClinoStar workflow. This collaboration addresses cell lines where natural ECM production falls short, providing animal-free extracellular balance. Vitrogel allows cells to communicate, connect, and behave like true 3D cultures. The partnership includes joint application notes and is designed to improve research outcomes for problematic cell lines.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

InSphero develops 3D cell culture technologies and organoid-based assay platforms for drug discovery. Highly comparable as a direct peer in 3D cell culture and organoid technology, though more services-led than CelVivo's hardware-led model.

TypeDirect peer
Description

Stemcell Technologies provides reagents, tools, and instruments for cell culture, including organoid and 3D culture workflows. Comparable in serving the same academic and pharma researcher base with cell culture and 3D culture solutions.

3Corning Life Sciences
TypeBroad incumbent
Description

Corning offers Matrigel, spheroid microplates, and a wide portfolio of cell culture consumables. Comparable as a broad incumbent in cell culture and 3D culture, with much greater scale and distribution.

TypeBroad incumbent
Description

Thermo Fisher's Gibco and Nunc brands dominate cell culture media, reagents, and instruments. Comparable as a broad incumbent in the lab cell culture ecosystem, including emerging 3D culture offerings.

TypeBroad incumbent
Description

Lonza provides cell and gene therapy manufacturing, bioreactors, and cell culture solutions. Comparable as a broad incumbent in bioprocess and cell culture, with overlapping bioreactor expertise.

TypeBroad incumbent
Description

Sartorius supplies bioprocessing equipment, including single-use bioreactors and cell culture analytics. Comparable as a broad incumbent whose bioreactor and single-use consumable portfolio overlaps with CelVivo's ClinoReactor.

TypeEmerging player
Description

MIMETAS develops organ-on-chip platforms (OrganoPlate) for 3D cell culture and disease modeling. Comparable as an emerging player in 3D cell culture with a different enabling technology (microfluidics) but overlapping pharma/research customer base.

8CN Bio
TypeEmerging player
Description

CN Bio builds organ-on-chip and microphysiological systems for drug discovery. Comparable as an emerging 3D cell culture player with overlapping pharma customer base and disease-modeling applications.

TypeEmerging player
Description

Emulate develops organ-on-chip technology (Liver-Chip, etc.) for preclinical testing. Comparable as an emerging player in human-relevant in vitro models, competing for pharma preclinical mindshare against CelVivo.

TypeRegional player
Description

Reprocell provides iPSC-derived cells, organoids, and 3D culture services, primarily in Japan/APAC. Comparable as a regional player in 3D cell culture and organoid services with limited direct overlap in CelVivo's European/North American base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CelVivo

3D Cell Culture Laboratory Instrumentscelvivo.com

CelVivo is a Danish biotech company that develops clinostat-based 3D cell culture hardware (ClinoStar 2 and ClinoReactor) plus consumables and a cloud monitoring service, selling primarily to academic researchers, pharmaceutical/biotech firms, and medical research groups via direct sales and a global distributor network spanning 35+ countries.

What CelVivo does

CelVivo ApS is a Danish biotechnology company founded in 2014 and headquartered in Odense, Denmark, with a wholly-owned US subsidiary (CelVivo, Inc.) in Chevy Chase, Maryland. It develops and sells clinostat-based 3D cell culture systems that grow cells in a stress-free, low-shear laminar-flow environment intended to mimic in vivo physiological conditions for organoid development, tissue engineering, and related research. Its core hardware products are the ClinoStar 2 (a clinostat integrated into a CO2 incubator) and the ClinoReactor (a patent-pending single-use bioreactor with a 10 mL growth chamber), supplemented by a Hypoxia Module accessory and the CelVivo Cloud remote-monitoring service. The technical narrative centers on the "RARE" framework — Relevance, Abundance, Reproducibility, Ease — claiming up to 100% utilization of cell cultures and superior organoid growth versus conventional methods.

CelVivo sells capital equipment, single-use consumables, and after-sales service to academic and research institutions, pharmaceutical and biotechnology companies, and medical research groups. The business model is hardware-led with a consumable and service tail: pricing is quote-based against an unpublished price list, payment terms are typically 30 days from invoice, and up to 50% advance payment may be required. Distribution combines direct sales — handled in-house for the Americas via the US subsidiary — with a network of named regional distributors covering APAC (e.g., Yamato Scientific in Japan, Sino BioTool in China), Central and Southern Europe (e.g., ALAB in Poland, Cytosens in Italy and Spain), the Middle East and Africa (Seperations in South Africa), and additional partners in Singapore, Korea, India, Taiwan, the Czech Republic, and Switzerland. A co-development partnership with TheWell Bioscience integrates Vitrogel hydrogel into the ClinoReactor workflow for cell lines with insufficient natural ECM production.

The company is privately held and bootstrapped, with 1-10 employees and no disclosed funding rounds, revenue, or institutional investors in the available source material. It protects its technology through registered trademarks for ClinoStar and ClinoReactor and a patent-pending filing on the ClinoReactor bioreactor. The operating footprint spans roughly 35+ countries, though no quantitative revenue or growth data is publicly disclosed, and named customer logos are predominantly individual academic and research institutions rather than large anchor enterprise accounts.

CelVivo firmographics

Firmographics
Name
CelVivo
Legal name
CelVivo ApS
Website
https://celvivo.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
CelVivo is a Danish biotech company that develops clinostat-based 3D cell culture hardware (ClinoStar 2 and ClinoReactor) plus consumables and a cloud monitoring service, selling primarily to academic researchers, pharmaceutical/biotech firms, and medical research groups via direct sales and a global distributor network spanning 35+ countries.
Ownership category
akta.pro rank

CelVivo industry classification

Industry
Product category
3D Cell Culture Laboratory Instruments
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • 3D cell culture
  • Organoid technology
  • Laboratory bioreactors
  • Clinostat equipment
  • Cell culture instruments

Where CelVivo is headquartered

Location

Headquarters

HQ city
Odense
HQ country
Denmark
HQ region
Europe

Offices3 records

Markets served

CelVivo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. 3D Cell Culture Equipment Sales: Sale of ClinoStar and ClinoReactor systems for 3D cell culture, including hardware and control units. The ClinoStar has a 1-year warranty from delivery date.
  2. Consumables: Sale of ClinoReactor consumables. The ClinoReactor has a shelf life of 1 year and is sterilized via e-beam. Operating time in incubator is 10 days. Consumables are not covered by warranty.
  3. After-Sales Service and Repairs: CelVivo provides after-sales service and repairs on all products. Cost for repair and transport is covered by the buyer if outside warranty.

Pricing tiers

ModelBillingPrice
OtherAnnualCustom pricing based on product configuration and volume

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

CelVivo product offering

Product offering

Core offering

CelVivo designs, manufactures, and sells hardware and consumables for 3D cell culture. Its flagship ClinoStar 2 system is a clinostat that fits inside a standard CO2 incubator to grow organoids and tissue in a low-shear, stress-free environment. The company complements the platform with the ClinoReactor single-use bioreactor, a Hypoxia Module accessory, and the Celvivo Cloud remote monitoring service.

Product overview

CelVivo offers a unified 3D cell culture system centered on the ClinoStar 2 platform, a clinostat-based device that incorporates directly into standard CO2 incubators. The system is complemented by the ClinoReactor, a single-use all-in-one bioreactor with a 10 mL growth chamber, and the Hypoxia Module for low-oxygen research applications. The Celvivo Cloud service adds remote monitoring and control capabilities, allowing researchers to monitor experiments from any location. Together, these products enable stress-free 3D cell and organoid culture with full reproducibility and relevance to in vivo conditions.

Differentiator

Problem solved

Functional benefit

Brands

  • ClinoStar: A clinostat for 3D cell culture incorporated in a CO2 incubator, allowing culture of cells in 3D in a single unit. The most user-friendly system for working with organoids.
  • ClinoReactor
  • ClinoStar 2
  • Hypoxia Module
  • Celvivo Cloud

Products and services

  • ClinoStar 2 The ClinoStar 2 is a clinostat for 3D cell culture that fits inside a standard CO2 incubator, enabling users to culture cells in 3D within a single unit. It provides a stress-free, low-shear environment for organoid development and tissue engineering, with remote monitoring via Celvivo Cloud, push-button auto decontamination, and stand-alone ergonomic design that eliminates the need for laminar flow bench work. It is sold to academic researchers, pharmaceutical R&D teams, and biotech laboratories.
  • ClinoReactor The ClinoReactor is a single-use, all-in-one bioreactor with a 10 mL growth culture chamber, semi-permeable membrane for CO2 equilibrium, and an integrated humidification system. Its front wall doubles as a click-on/off lid, providing petri-dish-like access to the chamber, and it operates for 10 days inside an incubator with a one-year shelf life and e-beam sterilization. It is sold as a consumable used with the ClinoStar platform for 3D cell culture workflows.
  • Hypoxia Module The Hypoxia Module is an add-on for the ClinoStar system that allows researchers to control oxygen conditions, enabling experiments under low-oxygen (hypoxic) environments for studying tumor microenvironments and other oxygen-related biological questions.
  • Celvivo Cloud Celvivo Cloud is a cloud-based remote monitoring and control service that lets ClinoStar users monitor and manage their cell culture environment from any device, anywhere in the world. It is offered to ClinoStar owners as an add-on service.

Quantifiable outcome

  • Up to 100% utilization of cell cultures
  • +2 more outcomes

Companies that use CelVivo

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

CelVivo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

CelVivo partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TheWell BiosciencecoreStrategic or Co-development PartnerCelVivo has partnered with TheWell Bioscience to integrate Vitrogel hydrogel matrix into the ClinoStar workflow. This collaboration addresses cell lines where natural ECM production falls short, providing animal-free extracellular balance. Vitrogel allows cells to communicate, connect, and behave like true 3D cultures. The partnership includes joint application notes and is designed to improve research outcomes for problematic cell lines.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

CelVivo competitors and assessment

Company assessment

Direct peers

  • InSphero: InSphero develops 3D cell culture technologies and organoid-based assay platforms for drug discovery. Highly comparable as a direct peer in 3D cell culture and organoid technology, though more services-led than CelVivo's hardware-led model.
  • Stemcell Technologies: Stemcell Technologies provides reagents, tools, and instruments for cell culture, including organoid and 3D culture workflows. Comparable in serving the same academic and pharma researcher base with cell culture and 3D culture solutions.

Broad incumbents

  • Corning Life Sciences: Corning offers Matrigel, spheroid microplates, and a wide portfolio of cell culture consumables. Comparable as a broad incumbent in cell culture and 3D culture, with much greater scale and distribution.
  • Thermo Fisher Scientific: Thermo Fisher's Gibco and Nunc brands dominate cell culture media, reagents, and instruments. Comparable as a broad incumbent in the lab cell culture ecosystem, including emerging 3D culture offerings.
  • Lonza: Lonza provides cell and gene therapy manufacturing, bioreactors, and cell culture solutions. Comparable as a broad incumbent in bioprocess and cell culture, with overlapping bioreactor expertise.
  • Sartorius: Sartorius supplies bioprocessing equipment, including single-use bioreactors and cell culture analytics. Comparable as a broad incumbent whose bioreactor and single-use consumable portfolio overlaps with CelVivo's ClinoReactor.

Emerging players

  • MIMETAS: MIMETAS develops organ-on-chip platforms (OrganoPlate) for 3D cell culture and disease modeling. Comparable as an emerging player in 3D cell culture with a different enabling technology (microfluidics) but overlapping pharma/research customer base.
  • CN Bio: CN Bio builds organ-on-chip and microphysiological systems for drug discovery. Comparable as an emerging 3D cell culture player with overlapping pharma customer base and disease-modeling applications.
  • Emulate: Emulate develops organ-on-chip technology (Liver-Chip, etc.) for preclinical testing. Comparable as an emerging player in human-relevant in vitro models, competing for pharma preclinical mindshare against CelVivo.

Regional players

  • Reprocell: Reprocell provides iPSC-derived cells, organoids, and 3D culture services, primarily in Japan/APAC. Comparable as a regional player in 3D cell culture and organoid services with limited direct overlap in CelVivo's European/North American base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

CelVivo social profiles

Digital presence

CelVivo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CelVivo leadership team

Management profile

Number of profiles

CelVivo subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

CelVivo funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CelVivo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CelVivo

What does CelVivo do?

CelVivo designs, manufactures, and sells hardware and consumables for 3D cell culture. Its flagship ClinoStar 2 system is a clinostat that fits inside a standard CO2 incubator to grow organoids and tissue in a low-shear, stress-free environment. The company complements the platform with the ClinoReactor single-use bioreactor, a Hypoxia Module accessory, and the Celvivo Cloud remote monitoring service.

Is CelVivo a public or private company?

CelVivo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CelVivo founded?

CelVivo was founded in 2014. It employs 11 to 50 people.

Where is CelVivo based?

CelVivo is headquartered in Odense, Denmark, in the Europe region.

How does CelVivo make money?

Three revenue lines are on record. 3D Cell Culture Equipment Sales are the primary driver. The others are consumables and after-Sales Service and Repairs.

Who are CelVivo's main competitors?

Direct peers on record are InSphero and Stemcell Technologies. Broad incumbents are Corning Life Sciences, Thermo Fisher Scientific, Lonza and Sartorius. Emerging players are MIMETAS, CN Bio and Emulate. Reprocell is listed as a regional player.

Does CelVivo have an API?

No public API is recorded for CelVivo.

What industry is CelVivo in?

CelVivo's product category is 3D Cell Culture Laboratory Instruments. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers), with a secondary code of HLAAAJAC, Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Analytica-worldDanish 3D cell culture company Celvivo raises USD 6.6 million and appoints new CEO for global scale-upCelvivo raised USD 6.6 million from existing investors EIFO and T&W Holding plus new investor VOMA Holding. The funds will accelerate scale-up, commercial expansion, and product development. The company also appointed Jacob Philipsen as CEO, succeeding Peter Willems-Alnøe.CelvivoPress Release: Celvivo secures DKK 42 million in funding and appoints new CEO to lead next growth phaseCelvivo raised DKK 42 million from existing investors EIFO and T&W Holding plus new investor VOMA Holding. The funds will support scale-up, commercial expansion, and product development. CEO Jacob Philipsen was appointed to lead the next growth phase.CelvivoBlog: Refining Biomedical Research Beyond Animal ModelsIn April 2025, the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing requirements for certain drug classes, and the National Institutes of Health (NIH) launched an initiative to establish the Office of Research Innovation, Validation, and Application (ORIVA) to scale non-animal research approaches. CelVivo's Chief Research Officer argues that clinostat-based 3D culture systems like the company's ClinoStar and ClinoReactor can address the need for reproducible, human-relevant organoid models by reducing variability and enabling physiologically accurate drug testing. The author contends that these technologies represent a practical pathway toward replacing animal models in preclinical research, though challenges around standardization and validation remain.BiotechniquesFrom the floor at Neuroscience 2024The article reports on presentations and product showcases by several biotechnology companies at the Neuroscience 2024 conference in Chicago. It highlights specific technologies from CelVivo, Zymo Research, Meteor Biotech, and Cell Microsystems designed to advance neuroscience research through cell culture, sequencing, and analysis tools. The content serves as a summary of industry partner activities rather than a report on a singular corporate event.